{ "items": [ "\n\n
\n \n 15 June 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nThe research will use the Kennedy\u2019s state-of-the-art technology to understand the effect of EVOLVE molecules in the immune response to tumours.
\n \n\n\n \n 1 June 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA team led by Alex Clarke at the Kennedy Institute has identified how high mitochondrial activity regulates antibody responses crucial for immunity but is also necessary for the development of lymphoma.
\n \n\n\n \n 24 May 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publication\n \n \n\n \n\n\n
\n \n\n \n \n \nInsights into a specific macrophage population suggest that these cells could drive inflammation in rheumatoid arthritis. Understanding their complex role could lead to better treatments for patients.
\n \n\n\n \n 17 May 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nAbsci will apply its generative AI platform to The Kennedy Institute\u2019s immunology biorepository to speed the discovery and development of multiple therapies
\n \n\n\n \n 10 May 2023\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Kennedy professor is one of eight researchers from Oxford University who received a prestigious fellowship from the Royal Society in recognition of their work in the fields of science and medicine.
\n \n\n\n \n 31 March 2023\n \n
\n\n \n \n \n\n \n \n \nA new study led by Oxford researchers has found vedolizumab can induce remission in patients who have chronic pouchitis after surgery for ulcerative colitis.
\n \n\n\n \n 30 March 2023\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nAccording to a new Oxford study, changing clinical practice for finger injuries in children could save the NHS \u00a3720,000 per year.
\n \n\n\n \n 22 February 2023\n \n
\n\n \n \n \n\n \n \n \nA new study in The EMBO Journal has revealed how fat tissues might provide a protective role in intestinal inflammation opening new lines of research into the treatment of inflammatory bowel diseases.
\n \n\n\n \n 16 February 2023\n \n
\n\n \n\n \n\n \n \n \n \n Funding\n \n \n\n \n\n\n
\n \n\n \n \n \nKennedy Institute researchers Mariana Borsa and Edward Jenkins have both been awarded Sir Henry Wellcome Postdoctoral Fellowships, which give recently qualified postdoctoral researchers the opportunity to start independent research careers.
\n \n\n\n \n 6 February 2023\n \n
\n\n \n \n \n\n \n \n \nIn his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.
\n \n\n\n \n 4 January 2023\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nWe spoke to Irina Udalova and Stephen Sansom about the Kennedy\u2019s new single cell facility and how it will enhance research at the Institute and beyond.
\n \n\n\n \n 22 December 2022\n \n
\n\n \n\n \n\n \n \n \n \n oacentre\n \n \n\n \n\n\n
\n \n\n \n \n \nA new study, published in Science Translational Medicine by researchers at the University of Oxford has identified that Talarozole, a drug that is known to increase retinoic acid, was able to prevent osteoarthritis (OA) in disease models.
\n \n\n\n \n 6 December 2022\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nA generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.
\n \n\n\n \n 1 December 2022\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nConrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England
\n \n\n\n \n 30 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nAlex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation\u2019s sixth Emerging Leaders Prize.
\n \n\n\n \n 29 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nWe recently welcomed our Scientific Advisory Board (SAB) and the Kennedy Trust Scientific Review Board (TSRB) to the Institute to review our current activities and future plans.
\n \n\n\n \n 22 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nTo respond to advances in technology and try to answer an increasing range of biological questions, the Kennedy Institute has invested in a high-performance computing facility. We speak to Brian Marsden, Associate Professor of Research Informatics at the Kennedy to find out more.
\n \n\n\n \n 16 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at the Kennedy Institute of Rheumatology and Oxford Population Health\u2019s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren\u2019s disease.
\n \n\n\n \n 19 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nWelcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.
\n \n\n\n \n 17 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n Funding\n \n \n\n \n\n\n
\n \n\n \n \n \nHealth and care research in Oxford is to receive \u00a3122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.
\n \n\n